Introduction
============

*Enterobacter aerogenes* is a Gram-negative bacterium that is ubiquitous in the human gastrointestinal tract and various other environments and is generally non-pathogenic to healthy humans ([@B9]). However, *E. aerogenes* has become an important opportunistic pathogen since the early 1990s and has frequently been isolated from respiratory, urinary, blood, and gastrointestinal tract infections ([@B30]). Moreover, *E. aerogenes* has been reported to readily cause septic shock in patients, thus leading to high mortality rates ([@B31]). *E. aerogenes* strains that are isolated from hospitalized patients generally exhibit high resistance to commonly used broad-spectrum antibiotics ([@B13]; [@B8]; [@B32]). Consequently, this species has been considered an important emerging multidrug resistant (MDR) pathogen over the past two decades ([@B10]).

Surface polysaccharides, particularly the heat-stable somatic (O) and/or capsular (K) antigens, are major targets for both host immune systems and bacteriophages and therefore are some of the most variable constituents of the cell. The genes involved in surface polysaccharide synthesis are generally arranged in a gene cluster, and most of the variation among polysaccharides is due to genetic variation in the polysaccharide gene clusters (PSgcs), thereby providing the molecular basis for serotyping. These genes are commonly classified into three main classes: (i) nucleotide sugar precursor synthesis genes for sugars that are specific to the particular polysaccharide; (ii) sugar transferase genes that are associated with the O- or K-unit assemblies, and which are specific for the donor and acceptor sugars and generate a specific linkage between them; and (iii) genes (*wzx/wzy* or *wzm/wzt*) for O- or K-unit translocation and polymerization ([@B34]). In addition to the three gene classes above, a *wzi-wza-wab-wzc* gene set that is highly conserved among different serotypes exists in the locus of most *Klebsiella* capsular types and the group 1 capsule of *E. coli* ([@B52]; [@B40]). The protein complex Wza/b/c accepts the polymer made by Wzy and transports it to the cell surface, forming the capsule (K) antigen ([@B52]). The remainder, Wzi, is proposed to play a role in capsule assembly, but the mechanistic details of this process remain unclear ([@B43]). The complete O-antigen is ligated to the lipid A/core by WaaL, which is encoded by the *waaL* gene in the core gene cluster, thus forming the LPS structure. The K-repeat polymer can also be added to the lipid A/core, and this is known as the K~LPS~, which does not require the Wza/b/c complex ([@B23]).

The recent development of molecular detection methods, including pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), plasmid fingerprinting (PF), restriction fragment length polymorphism (RFLP) and gene-specific PCR, have advanced the ability to identify pathogens. Ribotyping, arbitrarily primed PCR and PFGE assays have been reported to be used for epidemiological study of nosocomial *E. aerogenes* isolates ([@B17]; [@B24]). However, serotyping based on the diversity of surface polysaccharides that underlie antigenic schemes remains the 'gold standard' for detecting pathogenic strains in clinical specimens and environmental samples, as well as for epidemiological surveillance and tracing ([@B50]). In contrast to widely studied pathogens, including *Salmonella* spp. ([@B18]), *E. coli* ([@B39]), *S. pneumoniae* ([@B27]), and *Vibrio parahaemolyticus* ([@B6]) and other major pathogens, antigenic schemes for some important emerging pathogens have not been established. Furthermore, even the genetic and structural basis for serological diversity has not yet been elucidated in several of these emerging pathogens. The development of next-generation sequencing (NGS) has made it possible to rapidly detect almost all genetic features of numerous pathogens, including elucidation of putative PSgcs in novel, emerging pathogenic bacteria. Consequently, a molecular serotyping scheme could be developed based on the sequence diversity of PSgcs that is theoretically consistent with the traditional antigenic system based on the structural diversity of surface polysaccharide antigens.

Here, the genomes of 23 *E. aerogenes* strains were sequenced, and eight forms of putative PSgcs (1--8) were obtained and analyzed, providing confirmation of the molecular serotyping scheme for *E. aerogenes*. Antisera against type strains that represented each PSgc type were then produced and showed good absorption specificity to their homologous strains, indicating a high level of accuracy for the molecular serotyping scheme that we presented. Furthermore, a Luminex bead-based suspension array targeting these eight PSgc types was developed and evaluated for specificity and sensitivity in double-blind tests. We then examined another 86 *E. aerogenes* strains with genome sequences available in the GenBank database and identified an additional seven new gene cluster types (PSgcs 9--15).

Materials and Methods {#s1}
=====================

Sequencing and Bioinformatic Analyses
-------------------------------------

Bacterial cultivation and DNA extraction were conducted in a BS-2 lab.

Whole-genome sequencing of 23 *E. aerogenes* strains (Supplementary Table [1](#SM1){ref-type="supplementary-material"}) was performed on the Solexa paired-end sequencing platform. Genomic DNA was sheared, polished, and prepared using the Illumina Sample Preparation Kit according to the manufacturer's protocols. Genomic libraries were constructed that contained 500-bp paired-end inserts, and sequencing was performed with Solexa sequencing technologies (Illumina, Inc.) to produce ∼100-fold coverage for each genome. Sequence reads were assembled using the *de novo* genome-assembly program Velvet to generate multi-contig draft genomes. Gaps within the putative PSgc were closed by directed PCR, and the products were sequenced using BigDye terminator chemistry on ABI 3730 capillary sequencers.

Artemis ([@B45]) was used to annotate genes, and the lockMaker program ([@B21]) was used to identify conserved motifs. BLAST and PSI-BLAST ([@B1]) were used to search genes and proteins against available databases, including GenBank^[1](#fn01){ref-type="fn"}^ and the Pfam protein motif databases^[2](#fn02){ref-type="fn"}^. The TMHMM analysis program v2.0^[3](#fn03){ref-type="fn"}^ was used to identify potential transmembrane domains within protein sequences.

Identification of Putative PSgcs From Genomes
---------------------------------------------

Eighty-six *E. aerogenes* genome sequences were downloaded from the GenBank database (Supplementary Table [1](#SM1){ref-type="supplementary-material"}) and combined with the 23 genome sequences obtained in this study to assess PSgc distributions. Putative PSgc sequences that were located between the two housekeeping genes *galF* and *gnd* were retrieved from the genomes. PSgc sequences sharing high DNA or protein level identity (\>97%) and possessing the same gene organization were considered identical serotypes.

Preparation of Antigens for Immunization
----------------------------------------

All strains that were used for immunization were cultivated in 400 ml of media and were harvested by centrifugation at 5,000 × *g* for 20 min, washed in 20 ml of 0.85% NaCl, and suspended in 20 ml of 0.85% NaCl (approximately 10^11^ cells/ml). The cell suspension was subsequently treated with 0.5% formaldehyde overnight. Only strains that did not exhibit autoagglutination were used for immunization. The resultant antigens were stored at 4°C.

Production of Antisera
----------------------

Adult New Zealand white rabbits (2.5 kg weight) were injected intravenously with the prepared antigens. Three rabbits were used for each *Enterobacter* strain. At 3-day intervals, injections were given at doses of 0.5, 1, 2, and 4 ml. Rabbits were exsanguinated 8 days after the final injection, and the separated antisera were stored at 4°C.

Tube Agglutination
------------------

Serotyping and titer determination were performed by tube agglutination. For antigen preparation, cultures were taken from agar plates after incubation at 37°C overnight, autoclaved, and then washed in 20 ml of 0.85% NaCl, and suspended in 20 ml of 0.85% NaCl. Tube agglutination was performed in 96-well U-bottom microtiter plates with 25 μl of antigen and 25 μl of twofold diluted antiserum in PBS (50 mM phosphate buffer, 150 mM NaCl, pH 7.2). Microtiter plates were incubated at 37°C for 4 h and then stored at 4°C overnight. The titer was determined based on the most diluted concentration of a serum that gave a positive reaction compared to the PBS negative control.

Antiserum Absorption
--------------------

To assess the absorption of agglutinins, cell suspensions were prepared by inoculating moist, thickly poured (∼1 ml medium per plate) 90-mm infusion agar plates. Plates were incubated in an upright position for 18--24 h at 37°C. Cultures from the plates were then suspended in 0.85% NaCl and treated with 0.5% formaldehyde overnight and then centrifuged at 5,000 × *g* for 20 min. The cell pellets were then gently washed with 0.85% NaCl three times and resuspended in 2 ml of antisera. The mixtures were incubated at room temperature for 2 h and subsequently centrifuged at 10,000 × *g* for 15 min, and the supernatants were collected. The absorbed antisera were then tested against all antigens that reacted with the unabsorbed antisera. This process was repeated until cross-reactions no longer occurred.

Design of Primers and Probes
----------------------------

PSgc1-8 specific primers and probes were designed based on the DNA sequences that were obtained in this study using Primer Premier v5.0 software (Premier Biosoft International, Palo Alto, CA, United States). The specificity of each individual primer pair was confirmed using BLAST program and was subsequently validated by a single PCR amplification. For Luminex-based detection, each probe was synthesized with a 5′ amino modifier C12 that enabled coupling to the carboxyl group located on the microsphere, and each reverse primer was labeled with biotin at its 5′ end.

Multiplex PCR Amplification
---------------------------

Multiplex PCR amplification was performed in a 50 μl reaction mixture consisting of 100 ng of genomic DNA, 1× Goldstar PCR buffer, 20 μM of each deoxynucleoside triphosphate (dNTP), 2.5 units of Goldstar DNA polymerase, 0.5 μM of each forward primer, and 2 μM of each reverse primer. The reaction parameters were as follows: hot start at 95°C for 5 min; amplification stage of 30 cycles at 95°C for 30 s, 60°C for 30 s, and 72°C for 1 min, followed by a final extension at 72°C for 5 min.

Hybridization and Luminex Analysis
----------------------------------

Each PSgc probe was bound to a different carboxylated microsphere as described previously ([@B7]). The working microspheres consisted of eight types of beads, and each bead was coupled to a PSgc-specific probe. Hybridization was performed in a 50 μl mixture that included 17 μl of biotin-labeled PCR product and 33 μl of working microspheres, with denaturation at 95°C for 10 min and incubation at 55°C for 17 min in a thermal cycler. The hybridization product was then transferred to a filter plate and washed three times with 1× TMAC buffer at 1,000 rpm for 1 min. For detection, 80 μl of streptavidin-R-phycoerythrin in 1× TMAC buffer was added to each well, followed by incubation at 53°C for 20 min. Finally, the signals for each set of beads were measured using a Bio-plex 100 reader (Bio-Rad) according to the manufacturer's protocol. Data were analyzed using Bio-plex Manager 4.0, and the data are presented as the median fluorescence intensity (MFI). The cut-off value for a positive result was defined as three times greater than the mean MFI value of the background.

Ethics Statement
----------------

All animal experiments were performed in accordance with the standards established in the Guide for the Care and Use of Laboratory Animals published by the Institute of Laboratory Animal Resources of the National Research Council (United States). The animal research procedures were approved by the Institutional Animal Care Committee at Nankai University and Tianjin Institute of Pharmaceutical Research New Drug Evaluation Co., Ltd. (IACUC number: 2016032102), Tianjin, China. Efforts were made to minimize animal suffering and to reduce the number of animals used.

Results
=======

General Features of Putative PSgcs in *E. aerogenes*
----------------------------------------------------

In this study, genomes were sequenced from two reference *E. aerogenes* strains from the American Type Culture Collection (ATCC), two from the German Collection of Microorganisms and Cultures (DSMZ), and 19 clinical strains that were isolated from the Shanghai Municipal Center for Disease Control and Prevention (SCDC) during 2012--2015 (Supplementary Table [1](#SM1){ref-type="supplementary-material"}). Putative PSgc regions of *E. aerogenes* were first located by us, and a total of eight different putative PSgc types were found. All eight putative PSgcs mapped between two housekeeping genes, *galF* and *gnd*, and ranged in size from 11,194 bp to 23,479 bp, with all genes transcribed from *galF* and *gnd*. The average % GC content of all putative PSgcs is ∼40%, which is significantly lower than for the *E. aerogenes* genome as a whole (55%). The PSgc allocation and accession numbers for all type strains are summarized in Supplementary Table [2](#SM2){ref-type="supplementary-material"}.

In each PSgc, the conserved gene set *cpsACP-wzi-wza-wzb-wzc* was located at the 5′ end. Further, an initial glycosyltransferase gene (*wbaP* or *wcaJ*) was present, whose products have been characterized as initial glycosyl transferases (ITs) that transfer galactose-1-phosphate or glucose-1-phosphate, respectively, to undecaprenol phosphate to initiate polysaccharide synthesis ([@B36]; [@B41]). In several PSgc types, *manCB*, which is responsible for the formation of GDP-D-Man ([@B35]; [@B42]), *rmlAB/vioAB* for dDTP-D-Qui4NAc ([@B51]), and *glf* for UDP-Gal*f* ([@B38]), were also presented. Biosynthetic pathways for all putative rare sugars present in *E. aerogenes* surface polysaccharides are indicated in Supplementary Figure [1](#SM4){ref-type="supplementary-material"}. Meanwhile, each PSgc possessed non-initial glycosyltransferase genes (GTs), and oligosaccharide unit processing genes were observed in most PSgc types (**Figure [1](#F1){ref-type="fig"}**). Characteristics of open reading frames (ORFs) for all putative PSgc types are summarized in Supplementary Table [3](#SM3){ref-type="supplementary-material"}.

![Schematic diagram of the eight putative PSgc types identified from the 23 *Enterobacter aerogenes* strain genomes sequenced in this study. Genes are represented by arrows and colored according to the gene key at the bottom with gene names indicated above each arrow.](fmicb-09-00501-g001){#F1}

A conserved 39 bp JUMPstar sequence has been reported to be present in the non-coding regions upstream of PSgcs in several bacteria, and it was proposed to play two possible roles, regulating the transcription of PSgcs and involvement in the recombination of sugar pathway and assembly genes between loci ([@B23]). We aligned the non-coding regions of each PSgc between *cpsACP* and *wzi* using MEGA 4 software and identified homologous JUMPstar sequences that were also present in these gene clusters (Supplementary Figure [2](#SM5){ref-type="supplementary-material"}).

The results outlined above indicate that the genetic region between *galF* and *gnd* should be a PSgc, and a potential molecular serotyping system could be presented based on the genetic diversity of PSgc types.

The Conventional Antigenic Scheme Correlated Well With the Molecular Serotyping System Based on PSgc Genetic Variation
----------------------------------------------------------------------------------------------------------------------

Antisera were prepared using each type strain that represented PSgc types 1--8 and tested against all isolates. The homologous and heterologous titers of these antisera are summarized in **Table [1](#T1){ref-type="table"}**. Generally, homologous titers were high, varying from 320 to 1280. However, none of the antisera were specific for only their homologous strains, with the exception of PSgc6 antiserum, and each antiserum resulted in unique cross-agglutination with one or more of the other antigens. Thus, the specific antisera needed to be absorbed with the corresponding heterologous antigens. Each antiserum agglutinated with only the corresponding homologous antigen after absorption, with serum titers ranging from 160 to 640 (**Table [2](#T2){ref-type="table"}**). The eight absorbed antisera were then tested against all available strains, and each produced specific agglutination only against the strains that carried the same PSgc. These results suggested that the traditional immunoassay system was perfectly consistent with the molecular serotyping scheme that we developed based on PSgc diversity.

###### 

Agglutination of absorbed *E. aerogenes* antisera.

                 Agglutinin titers to each PSgc type strain                                   
  ------- ------ -------------------------------------------- ----- ------- ----- ----- ----- -----
  PSgc1   1280   \-                                           80    \-      \-    \-    80    \-
  PSgc2   \-     320                                          \-    40      \-    \-    \-    \-
  PSgc3   \-     \-                                           640   \-      \-    \-    40    \-
  PSgc4   \-     160                                          \-    1,280   \-    \-    40    40
  PSgc5   \-     \-                                           20    \-      320   \-    \-    \-
  PSgc6   \-     \-                                           \-    \-      \-    320   \-    \-
  PSgc7   40     \-                                           40    \-      \-    \-    640   40
  PSgc8   \-     \-                                           40    20      \-    \-    \-    640
                                                                                              

###### 

Agglutination of absorbed *E. aerogenes* antisera.

                                Agglutinin titers to each PSgc type strain                                       
  ------- --------------------- -------------------------------------------- ----- ----- ----- ----- ----- ----- -----
  PSgc1   G5306, G5313          640                                          --    --    --    --    --    --    --
  PSgc2   G5307                 --                                           160   --    --    --    --    --    --
  PSgc3   G5313                 --                                           --    320   --    --    --    --    --
  PSgc4   G5305, G5313, G5319   --                                           --    --    320   --    --    --    --
  PSgc5   G5306                 --                                           --    --    --    160   --    --    --
  PSgc6   --                    --                                           --    --    --    --    320   --    --
  PSgc7   G2351, G5306, G5319   --                                           --    --    --    --    --    320   --
  PSgc8   G5306, G5307          --                                           --    --    --    --    --    --    320
                                                                                                                 

Development of a Multiplexed Luminex-Based Array
------------------------------------------------

Compared with nucleotide sugar precursor synthesis genes, glycosyltransferase genes and processing genes are very heterogeneous among serotypes owing to the wide range of possible sugar linkages, and they thereby provide the potential as genetic targets for serotypes ([@B33]). Furthermore, in contrast to the glycosyltransferase gene, the *wzy* gene encoding polymerase and the *wzx* gene encoding flippase are much more highly serotype determinative ([@B4]). Consequently, all primers and probes, except those for PSgc4, were designed based on *wzy*. For PSgc4, as it processes no *wzy* or *wzx* gene and as all three glycosyltransferase genes give no identity to any sequences via BLAST search, we selected *GT2* as the specific gene (**Table [3](#T3){ref-type="table"}**).

###### 

Primers and probes used in the multiplex Luminex-based assay.

  PSgc type   Primer sequence (5′--3′)   Size (bp)             Probe sequence   
  ----------- -------------------------- --------------------- ---------------- ------------------------
  PSgc1       TTGATTACTGGCGTTGGC         TTCACCCACAGACTGTTCC   192              GATGGCTTCAAATCAAGTAGT
  PSgc2       TTGTTCTGGAATCTGGGTT        CGCATCTTGAAGGGTTGTA   272              AGCACTATACATACCGATTAAA
  PSgc3       TTTGGTCGTACTGGTTAGG        AATCCCACCATTCAAACG    286              GCTATTACCAAATGCGAGTAG
  PSgc4       ATAGAGACGGTAAAGAAAGTAA     TCCCGATTTCTGTCCTTC    325              ACTGGGATACATGGTTGCG
  PSgc5       ATACTGGTGAGATGGAGGAA       CCCGCCATTTAGTCTTCC    276              ATACGCAGCATTTAAGAGAGA
  PSgc6       TTTCATCGCCCATTACCT         TTGAACAGCCAAGGAAAT    246              AAGGTTCAGTTGGGTTACGC
  PSgc7       TTATTTGTTGGACTGGCTAT       CAGGCGAATCAATAAAGG    232              ACCAGGTTTGGCAAGACA
  PSgc8       TTCAGGCTTGGGAATAGA         TGAGGCTTGCTATTCTACG   305              TTTCGTGGGACAAACGTAGA
                                                                                

Twenty-three *E. aerogenes* strains carrying PSgc1-8 and other pathogenic bacteria, including *Escherichia coli* (*n* = 2), *Salmonella* spp. (*n* = 2), *Shigella* spp. (*n* = 2), *Klebsiella pneumoniae* (*n* = 2), *Klebsiella oxytoca* (*n* = 2), *Enterobacter cloacae* (*n* = 1), *Enterobacter sakazakii* (*n* = 1), *Vibrio cholerae* (*n* = 2), *Vibrio parahaemolyticus* (*n* = 1), and *Citrobacter freundii* (*n* = 1), were used to assess the specificity of our multiplexed Luminex-based array. Multiplex PCR produced only a single band of the expected size for each type strain, and no non-specific amplicons were detected (**Figure [2A](#F2){ref-type="fig"}**). The subsequent Luminex-based array analyses indicated that each PSgc-specific probe detected the homologous strains correctly, and signals corresponding to heterologies or other pathogens were not observed (**Figure [2B](#F2){ref-type="fig"}**). A double-blind test with 97 clinical isolates that were obtained from the SCDC (i.e., hereafter referred to as Shanghai isolates) was performed. The results from these tests indicated that each isolate belonged to one of the eight PSgc types (PSgc1-8). Among these isolates, 32 (33%) contained PSgc4, 16 (16%) contained PSgc7, 12 (12%) contained PSgc 6, and 11 (11%) contained either PSgc2 or PSgc8, with other PSgc types each corresponding to \<10% of the isolates. This result was confirmed to be correct by ABI sequencing of each single PCR amplicon. The limit of detection for each of the target strains was determined by examining six serial 10-fold dilutions (10 ng to 0.1 pg) of each type strain's genomic DNA. As a result, the sensitivity of our assay using genomic DNA was 0.1 ng for each strain.

![Results of multiplex Luminex-based array. **(A)** Multiplex PCR of type strains representing each PSgc type. M, DNA Marker I (600, 500, 400, 300, 200, and 100 bp); 1, G2351; 2, G5305; 3, G5306; 4, G5307; 5, G5308; 6, G5310; 7, G5313; 8, G5319. **(B)** Specific detection based on the Luminex-based array. Biotin-labeled PCR products were separated by probe-coupled beads, and the hybridization signals are presented in terms of median fluorescence intensity (MFI) on the *y*-axis. Each sample representing the corresponding type strain is indicated on the *x*-axis. Data are combined from three independent experiments with error bars representing the standard deviation.](fmicb-09-00501-g002){#F2}

Molecular Serotyping Allocation of *E. aerogenes* Strains Based on Publicly Available Genome Sequences
------------------------------------------------------------------------------------------------------

Putative PSgc regions were extracted and identified from 86 *E. aerogenes* genomes that were obtained from the GenBank database. Thirty-two strains contained one of the seven PSgc types described above (PSgc3 was only found in G5306). In addition, another seven PSgc types (PSgc9-15) were distributed among the remaining 54 isolates (**Figure [3](#F3){ref-type="fig"}** and Supplementary Table [2](#SM2){ref-type="supplementary-material"}). Details for all ORFs corresponding to these seven types are provided in Supplementary Table [3](#SM3){ref-type="supplementary-material"}. Thus, our combined analyses identified a total of 15 PSgc types within the *E. aerogenes* molecular serotyping scheme. Among the 86 isolates, 37 (43%) contained PSgc10, followed by PSgc4 (12 of 86) and PSgc7 (7 of 86). Since the majority (74%) of the 86 strains were isolated from the United States and the remainder originated from other or unknown regions, the strains are tentatively referred to as "United States isolates" in the following discussion.

![Schematic diagram of the seven novel putative PSgc types that were identified in 54 strains whose genomes were publicly available. Genes are represented by arrows and colored according to the gene key at the bottom with gene names indicated above each arrow.](fmicb-09-00501-g003){#F3}

Within the 15 PSgcs, several anomalies were observed, including the following: (i) neither *wzx* nor *wzy* was annotated in PSgc4, PSgc14, or PSgc15, there was no *wzx* gene in PSgc7, and there was no *wzy* gene in PSgc2 or PSgc11. This atypical feature has been reported in *Klebsiella* capsular K11 and K34 without the *wzx* gene and in K29 and K50 without the *wzy* gene ([@B40]). In *Salmonella* serogroups A, B, and D1, the *wzy* genes also map far from the O-antigen gene cluster ([@B49]). Thus, it is likely that in the isolates with the above PSgc types, the functional *wzx/wzy* gene(s) are located outside of the PSgc region. However, they are difficult to annotate because of their low similarities to their counterparts, and further studies should be performed to confirm our hypothesis. (ii) In PSgc14, only *manB* was annotated. To our knowledge, this is the first evidence that *manC* and *manB* do not coexist in a gene cluster. (iii) It is noteworthy that the *ugd* and *gnd* genes are transcribed in the opposite direction in PSgc14 and that *ugd* is located at the 3′ end, meaning that there is probably a promoter at the end of the gene cluster.

Discussion
==========

In the present study, we developed a molecular serotyping system for *Enterobacter aerogenes* that is based on the PSgc region, which correlated perfectly with the conventional antigenic scheme. Hence, from the serotyping perspective, molecular PSgc-based typing and immunological serology are equally valid.

Differences in serotype distribution typically occur between geographical regions. For instance, among the genus *Shigella*, *S. flexneri* is globally and traditionally isolated frequently in resource-poor countries, with predominant serotypes including *S. flexneri* 2a, 3a, and 6, whereas *S. sonnei* is detected most commonly in high-income regions ([@B47]). Using the molecular serotyping scheme presented here, we revealed the occurrence of diverse clusters of *E. aerogenes* serotypes between far-distant regions (Supplementary Figure [3](#SM6){ref-type="supplementary-material"}). Strains containing the PSgc4 and PSgc7 types were the dominant serotypes among Shanghai isolates, while those with PSgc10 comprised the majority of United States isolates. It has been proposed that as one of the important components exposed on the cell surface, the bacterial surface polysaccharide is highly immunogenic and therefore subject to intense selection by the host immune system ([@B44]). This selection probably accounts for the maintenance of surface polysaccharide diversity and offers certain serotype(s) selective advantages in specific niches of different hosts. Overall, our findings suggest an important distinction for clinical microbiologists, infectious disease specialists, and infection control agencies, although more data should be gathered to confirm these results.

In this study, we prepared antisera for each PSgc type strain and performed agglutination tests, providing evidence of the reliability of our molecular serotyping scheme. However, several disadvantages exist in the development and application of serotyping antisera and should be noted. First, the development of an antigenic scheme is sophisticated and time consuming ([@B39]; [@B40]). Second, serotyping is labor-intensive, and only a few reference laboratories have the capacity to perform the analyses necessary to identify serotypes ([@B4]; [@B29]). In addition, conventional serological assays that are based on agglutination reactions are also limited by the risks of the high prevalence of non-typeable isolates due to the expression of novel polysaccharide forms, which is common in clinical isolates ([@B25]; [@B48]; [@B20]). The development of NGS technologies and automated data analysis pipelines has led to a number of proof-of-concept studies. These studies have suggested the possibility of increased resolution of the existing typing methods and potential advantages in public health microbiology for outbreak investigation and surveillance ([@B12]; [@B26]; [@B54]; [@B48]). Moreover, a few practical genomics-based approaches have been reported for the typing of bacteria and pathogen surveillance ([@B14]; [@B12]; [@B28]). However, a few shortcomings of NGS seem insurmountable for the routine detection and identification of pathogens over a short period of time including (i) the need for pure isolate cultures to obtain enough quality genomic DNA (usually 50 ng to 1 μg depending on different sequencing platforms); (ii) the lengthy turnaround time for library preparation and NGS platform sequencing runs; and (iii) the relatively high cost per isolate genome sequence. Consequently, typing methods that are based on PSgc-specific gene(s) are likely to be widely applied and economically viable alternatives for the foreseeable future. These methodologies, including RFLP, multiplex PCR, high throughput real-time PCR, and microarrays, have been widely utilized to identify serotypes based on sero-specific genes in major pathogens, including *E. coli* ([@B11]; [@B5]), *Streptococcus pneumonia*e ([@B2]), *Salmonella* spp. ([@B19]) and *Streptococcus suis* ([@B3]). The Luminex-based array system is a multiplexed microsphere-based suspension system that offers a molecular diagnostic platform and provides an open and attractive approach for simultaneous, high-throughput and multiplex detection of up to 100 targets in protein and nucleic acid studies ([@B53]). It has been approved by the US FDA for clinical diagnosis and has been used in various applications ([@B15]; [@B37]; [@B16]; [@B46]). Although the assay presented here only targeted *E. aerogenes* strains of types PSgc1-8, which appear to be more common in Shanghai and its surrounding environs, thus highlighting a limitation of the analysis (i.e., strain availability), the detection range of our assay could easily be expanded, as PSgc data can be obtained without limitation. Indeed, evaluation and revisiting of the serotyping system presented here should be performed as more isolates become available in the future. Regardless, our method shows significant potential for the characterization and epidemiological surveillance of this emerging pathogen.

We propose that all of the putative PSgc types identified in this study are responsible for the biosynthesis of capsular (K) antigens of *E. aerogenes*. The reasons for this supposition are as follows: (i) a conserved gene set, *cpsACP-wzi-wza-wzb-wzc*, is located at the 5′ end of each PSgc, which shares the typical features of most K antigen gene clusters in the genus *Klebsiella*, which is closely related to *E. aerogenes*, and the group 1 capsule gene clusters of *E. coli* ([@B52]; [@B40]). (ii) In the genome of *E. aerogenes* CAV1320, which contained PSgc5, another genetic region (loci: ABY61_23370 to ABY61_23395) containing six genes (*wzm*, *wzt*, *glf*, and *GT*1-3) was found upstream of *hisI*, which resembled an O antigen gene cluster (Supplementary Figure [4](#SM7){ref-type="supplementary-material"}). This region has been purported to have been introduced into an *E. coli* strain by an IS element, forming the O62 serotype in our recent study ([@B22]). We also examined the putative O antigen gene cluster among the strains for which whole genomes were available. Ten types of putative O-antigen gene clusters were characterized and distributed among 105 genomes, except for another four incomplete genomes due to poor sequencing (data not shown).

Seven of eight antisera gave slight serological cross-reactivity with heterologous antigens before absorption. It is hard to predict whether this is attributable to the similar polysaccharides, as no chemical structure has ever been reported. However, the PSgc types of each strain are quite different, meaning probably that no similar structures are shared among them. We therefore propose that the weak cross-reaction is due to the presence of common epitopes of other cell surface components. More detailed studies of each PSgc and the corresponding polysaccharide structures should be performed, and the correlation between them will be necessary to completely elucidate the heredity and evolution of *E. aerogenes*. In this regard, the results presented here provide a valuable framework from which to further assess the evolution of *E. aerogenes* surface polysaccharide structures in response to host and bacteriophage interactions.
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